21.5 C
New York
Tuesday, June 6, 2023

This Is Too Hot For Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Arrowhead Pharmaceuticals Inc. (ARWR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.16, or 0.40%, to $40.65. The Arrowhead Pharmaceuticals Inc. has recorded 10,501 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

As a NASDAQ listed company, ARWR falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $40.49 and fluctuated between $41.28 as its day high and $39.46 as its day low. The current market capitalization of Arrowhead Pharmaceuticals Inc. is $4.24B. A total of 0.7 million shares were traded on the day, compared to an average of 1.15M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, ARWR has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 12,225 shares. Over the last 12 months, there were 16 BUYs and 31 SELLs from insiders. Insiders purchased 587,470 shares during that period but sold 812,452.

In the most recent transaction, GIVEN DOUGLAS B sold 6,500 shares of ARWR for 40.90 per share on May 05. After the transaction, the Director now owns 117,635 company shares. In a previous transaction on May 04, Anzalone Christopher Richard sold 50,000 shares at 39.52 per share. ARWR shares that Chief Executive Officer owns now total 3,761,338.

Among the insiders who sold shares, Anzalone Christopher Richard disposed of 54,928 shares on May 03 at a per-share price of $39.14. This resulted in the Chief Executive Officer holding 3,761,338 shares of ARWR after the transaction. In another insider transaction, OLUKOTUN ADEOYE Y sold 11,350 shares at $32.65 per share on Mar 03. Company shares held by the Director now total 7,867.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for ARWR in the last 3 months, the mean price target is $61.93 with high estimates of $90.00 and low estimates of $27.00. In terms of 52-week highs and lows, ARWR has a high of $48.48 and a low of $23.09.

As of this writing, ARWR has an earnings estimate of -$0.76 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$1.27. The company reported an EPS of -$0.39 in the last quarter, which was -188.60% lower than expectations of $0.44.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $4.18, while its Total Shareholder’s Equity was $408.82M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.58.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles